We are delighted to announce a new strategic partnership with Patho-Logica.

Patho-Logica is an Israeli GLP accredited company that delivers tailored pre-clinical solutions for the Biotech, Pharma, Medical-Device and Diagnostic companies offering reliable data analysis, consulting solutions and pre-clinical histophalogical services to optimize product development.

The collaboration between Patho-Logica and Icrom will empower biopharmaceutical companies to streamline their drug development journey. By leveraging Patho-Logica’s customized preclinical solutions and Icrom’s adaptive pharmaceutical R&D and drug production capabilities, clients will experience enhanced feasibility studies, accelerated project timelines and increased product value.

We can’t wait to start growing stronger together!